Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to repeated and severe bouts of vomiting).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Virginia
• Treatments: Capsaicin

Criteria

Inclusion Criteria:

• At least 18 years old

• Diagnosis of cannabinoid hyperemesis syndrome

Exclusion Criteria:

• Patients who receive more than 2 anti-emetic therapies prior to screening for enrollment

• Patients who receive haloperidol as an anti-emetic therapy

• Pregnant women

• Prisoners